COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg

Clinical trial NCT04428684 · COMPLETED

Trial details

NCT number: NCT04428684
Sponsor: Peptigroupe Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dysfunctional Uterine Bleeding

Start date: 2018-10-29
Primary completion: 2020-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.